Neoantigen-Based Therapies Summit US 2022
Evvnt Promotion / evvnt
Archiv
24.10.2022 - 26.10.2022 Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 7:00 am to 4:00 pm
Kongressthemen
Returning for the 7th year, the Neoantigen-Based Therapies Summit remains your comprehensive guide to transforming the clinical development of cell and vaccine based neoantigen therapies.
Returning for the 7th year, the Neoantigen-Based Therapies Summit remains your comprehensive guide to transforming the clinical development of cell and vaccine based neoantigen therapies.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Stefan Scherer, Chief Executive Officer, 3T Biosciences, Jian Yan, Vice President, Research and Discovery, Geneos Therapeutics, Ramon Tiu, Head Of Oncology Cell Therapy Development, Takeda
Speakers: Stefan Scherer, Chief Executive Officer, 3T Biosciences, Jian Yan, Vice President, Research and Discovery, Geneos Therapeutics, Ramon Tiu, Head Of Oncology Cell Therapy Development, Takeda
Anfragen und Anmeldung:
https://go.evvnt.com/1257931-2?pid=4832
Herr Samuel Cowley
Gesundheitsversorgung, Public Health
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
